3-hydroxyflavone has been researched along with Uterine Cervical Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Duerksen-Hughes, PJ; Filippova, M; Krstenansky, JL; Tungteakkhun, SS; Yuan, CH | 1 |
| Chen, PN; Hsiao, YH; Hsin, MC; Lee, CY; Lin, CW; Wang, PH; Yang, SF | 1 |
| Bai, H; Yin, H | 1 |
| Chou, RH; Hsieh, SC; Hsieh, YH; Huang, MH; Huang, YC; Yu, YL | 1 |
| Cheng, CW; Hsieh, YH; Lin, CL; Lin, MT; Lin, TY; Tsai, JP; Wu, CC; Yang, SF | 1 |
| Bau, DT; Hsieh, SC; Hsieh, YH; Huang, YC; Tsai, SJ; Yang, SF; Ying, TH | 1 |
6 other study(ies) available for 3-hydroxyflavone and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Small molecule inhibitors of the HPV16-E6 interaction with caspase 8.
Topics: Apoptosis; Caspase 8; Caspase Inhibitors; Fas-Associated Death Domain Protein; Female; Flavones; Flavonols; Host-Pathogen Interactions; Human papillomavirus 16; Humans; Oncogene Proteins, Viral; Papillomavirus Infections; Repressor Proteins; Small Molecule Libraries; Uterine Cervical Neoplasms | 2012 |
Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines.
Topics: beta Catenin; Cell Movement; Female; Flavonols; HeLa Cells; Humans; MAP Kinase Signaling System; S100 Calcium-Binding Protein A4; Uterine Cervical Neoplasms | 2022 |
Engeletin suppresses cervical carcinogenesis in vitro and in vivo by reducing NF-κB-dependent signaling.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinogenesis; Cell Line, Tumor; Female; Flavonols; Glycosides; Humans; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Signal Transduction; Uterine Cervical Neoplasms | 2020 |
Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.
Topics: Adenocarcinoma; Cell Movement; Down-Regulation; Female; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Neoplasm Invasiveness; NF-kappa B; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator; Uterine Cervical Neoplasms | 2013 |
Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway.
Topics: Animals; Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Synergism; Female; Flavonoids; Flavonols; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Mitochondria; Niacinamide; Phenylurea Compounds; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Sorafenib; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 8; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Flavonols; HeLa Cells; Humans; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Uterine Cervical Neoplasms | 2012 |